Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Don't Bury Ariad's Patent Yet
Seeking Alpha
Thursday, August 27, 2009 - 8:14am
tags:
Ariad Pharmaceuticals, Eli Lilly, patents
Bayer Falls as Boehringer’s Pradaxa Seen Challenging Xarelto
Bloomberg
Thursday, August 27, 2009 - 7:40am
tags:
Bayer, Boehringer Ingelheim, blood thinners, Xarelto
Bristol-Myers' Orencia: Small Change, Big Impact?
Motley Fool
Thursday, August 27, 2009 - 7:38am
tags:
Orencia, Bristol-Myers Squibb
Biogen granted more time in drug dispute with Elan
Irish Independent
Wednesday, August 26, 2009 - 7:51pm
tags:
Biogen Idec, Elan, Tysabri
J&J warns of allergic reactions with HIV drug
Yahoo/AP
Wednesday, August 26, 2009 - 7:49pm
tags:
JNJ, HIV, FDA, Intelence
GSK seems to dismiss HGS rumour
FT.com
Wednesday, August 26, 2009 - 5:43pm
tags:
GSK, Human Genome Sciences, M&A
How to Play the Viropharma Buyout
Minyanville
Wednesday, August 26, 2009 - 5:42pm
tags:
ViroPharma, buyouts, Teva Pharmaceuticals
Amgen Falls Back on the Future
Motley Fool
Wednesday, August 26, 2009 - 5:41pm
tags:
Amgen, Aranesp
ISTA's Eye Drug Shows Success
Yahoo/Zacks.com
Wednesday, August 26, 2009 - 5:40pm
tags:
Ista, Alcon, Allergan, Xibrom
Schering-Plough asthma drug, oral contraceptive being reviewed by European regulators
Yahoo/AP
Wednesday, August 26, 2009 - 4:49pm
tags:
Schering Plough, asthma, contraceptives, EU, Europe
Boehringer Ingelheim Axes 600-900 Drug Sales Reps
BNET Pharma
Wednesday, August 26, 2009 - 3:44pm
tags:
Boehringer Ingelheim, layoffs
Merck says European Union agrees to review intravenous version of heart drug vernakalant
Yahoo/AP
Wednesday, August 26, 2009 - 3:42pm
tags:
Merck, EU, European, Vernakalant
J&J consolidating management, starting by eliminating new comprehensive care business unit
Yahoo/AP
Wednesday, August 26, 2009 - 10:34am
tags:
JNJ
Human Genome leads biotech stocks north
Marketwatch
Wednesday, August 26, 2009 - 10:22am
tags:
biotech, Human Genome Sciences, GSK, M&A
Vion Pharmaceuticals' Onrigin: Good Chance of FDA Approval
Seeking Alpha
Wednesday, August 26, 2009 - 10:21am
tags:
Vion Pharmaceuticals, FDA, Onrigin, AML
Pfizer unveils $214M biotech plant
Fierce Biotech
Wednesday, August 26, 2009 - 10:20am
tags:
Pfizer, Europe, biotech
Bristol-Myers says FDA broadens label for Orencia
Yahoo/AP
Wednesday, August 26, 2009 - 10:18am
tags:
FDA, Bristol-Myers Squibb, Orencia, rheumatoid arthritis
Glaxo Comes To The Defense Of Its alli
CNBC
Wednesday, August 26, 2009 - 10:18am
tags:
GSK, obesity, Alli, diet drugs
Endo Pharmaceuticals to Partner With ProStrakan to Commercialize FORTESTA(TM) in the U.S
PR Newswire
Wednesday, August 26, 2009 - 9:09am
tags:
Endo, Foretesta, partnerships, Prostrakan
Galderma Distributed Bogus PI for Skin Drug, FDA Claims
BNET Pharma
Wednesday, August 26, 2009 - 8:30am
tags:
Galderma, Tri-Luma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.